PureIMS expands leadership with Bram van Dijck, MBA, as new CEO whilst intensifying late-stage programs strategy
Roden — November 20, 2020 — PureIMS, a clinical stage
Automated Filling Equipment Allows Increase in the Maximum Dose to Be Filled in the Cyclops® High Dose Dry Powder Inhalation Device While Maintaining Dispersibility
I. Sibum, P. Hagedoorn, C.O. Botterman, H.W. Frijlink and F.
We are honoured that Harro Hӧfliger published an article on
PureIMS Initiates Phase 1 Clinical Trial to Evaluate Dry Powder Inhaler Formulation of Amikacin for Early Eradication Treatment of Tuberculosis
Delivery via inhaler could dramatically expand Amikacin’s clinical utility by